Magle Chemoswed Holding 관리

관리 기준 확인 2/4

Magle Chemoswed Holding CEO는 Justin Pierce, Jan2015 에 임명되었습니다 의 임기는 9.83 년입니다. 는 SEK 6.39M 가치에 해당하는 회사 주식의 0.94% 직접 소유합니다. 6.39M. 경영진과 이사회의 평균 재임 기간은 각각 5.3 년과 8.8 년입니다.

주요 정보

Justin Pierce

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	9.8yrs
CEO 소유권	0.9%
경영진 평균 재임 기간	5.3yrs
이사회 평균 재임 기간	8.8yrs

최근 관리 업데이트

Recent updates

Market Participants Recognise Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Earnings Pushing Shares 37% Higher

Jun 26

Magle Chemoswed Holding (STO:MAGLE) Has A Pretty Healthy Balance Sheet

Jun 19

Magle Chemoswed Holding's (STO:MAGLE) Earnings Are Of Questionable Quality

Apr 26

Earnings Tell The Story For Magle Chemoswed Holding AB (publ) (STO:MAGLE) As Its Stock Soars 28%

Mar 29

Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Price In Tune With Earnings

Oct 05

Should You Be Impressed By Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) ROE?

Jan 22

CEO

Justin Pierce (51 yo)

9.8yrs

테뉴어

Mr. Justin Pierce serves as Chief Executive Officer at Magle Chemoswed Holding AB (publ) since 2015.

리더십 팀

이름	위치	테뉴어	보상	소유권
Hans Lidgard	Founder & Chairman	11.8yrs	SEK 248.00k	데이터 없음
Justin Pierce	Chief Executive Officer	9.8yrs	데이터 없음	0.94% SEK 6.4m
Petra Sjolin	Chief Financial Officer	4.8yrs	데이터 없음	데이터 없음
Fredrik Andersson	Chief Operations Officer	5.8yrs	데이터 없음	데이터 없음
Megi Medzmariashvili	Legal Counsel	5.8yrs	데이터 없음	데이터 없음
Helena Thedius	Chief Marketing & Innovation Officer	2.2yrs	데이터 없음	데이터 없음
Simon Jegou	Chief Strategy Officer	2.8yrs	데이터 없음	데이터 없음

5.3yrs

평균 재임 기간

48yo

평균 연령

경험이 풍부한 관리: MAGLE 의 관리팀은 노련하고 경험 (평균 재직 기간 5.3 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Hans Lidgard	Founder & Chairman	11.8yrs	SEK 248.00k	데이터 없음
Sven-Christer Nilsson	Director	8.8yrs	SEK 138.00k	0.29% SEK 2.0m
Mats Pettersson	Director	8.8yrs	SEK 138.00k	1.17% SEK 8.0m
Claudia Lindwall	Staff Representative Director	3.8yrs	데이터 없음	데이터 없음
Malin Malmsjö	Director	8.8yrs	SEK 131.00k	데이터 없음
Ingela Fritzon	Staff Representative Director	5.8yrs	데이터 없음	데이터 없음
Martin Lidgard	Director	2.9yrs	SEK 131.00k	0.15% SEK 1.0m

8.8yrs

평균 재임 기간

61yo

평균 연령

경험이 풍부한 이사회: MAGLE 의 이사회는 경험(평균 재직 기간 8.8 년)으로 간주됩니다.

Magle Chemoswed Holding 관리

관리 기준 확인 2/4

주요 정보

최근 관리 업데이트

No independent directors

No independent directors

Magle Group Appoints New Chief Marketing and Innovation Officer

Magle Chemoswed Holding AB Announces the Resignation of Julia Kamber Rouhi from the Board of Directors of Magle Chemoswed Holding

No independent directors

Magle Chemoswed Holding AB (publ), Annual General Meeting, May 17, 2022

Recent updates

Third quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

New major risk - Shareholder dilution

Investor sentiment deteriorates as stock falls 18%

Magle Chemoswed Holding AB (publ) (OM:MAGLE) completed the acquisition of Amniotics AB (publ) (OM:AMNI).

New minor risk - Share price stability

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment improves as stock rises 16%

Market Participants Recognise Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Earnings Pushing Shares 37% Higher

Magle Chemoswed Holding (STO:MAGLE) Has A Pretty Healthy Balance Sheet

Magle Chemoswed Holding's (STO:MAGLE) Earnings Are Of Questionable Quality

First quarter 2024 earnings released: EPS: kr0.27 (vs kr0.27 in 1Q 2023)

Earnings Tell The Story For Magle Chemoswed Holding AB (publ) (STO:MAGLE) As Its Stock Soars 28%

Magle Chemoswed Holding AB (publ) (OM:MAGLE) made a tender to acquire 99.96% stake in Amniotics AB (publ) (OM:AMNI) from LSCS Invest AB, Deflexum AB, Marcus Larsson and other for SEK 10.9 million.

Full year 2023 earnings: EPS and revenues exceed analyst expectations

New minor risk - Financial data availability

Magle Chemoswed Holding AB (publ) to Report Q4, 2024 Results on Feb 26, 2025

No independent directors

New minor risk - Share price stability

Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) Price In Tune With Earnings

Investor sentiment improves as stock rises 16%

Full year 2022 earnings released: EPS: kr0.87 (vs kr0.39 in FY 2021)

Magle Chemoswed Holding AB 's Proprietary Product Axxo® Woundgel Receives Regulatory Approval in Kuwait

Magle Group's Vascular Embolic Product Embocept® S Receives Regulatory Approval in Argentina

No independent directors

Magle Group Appoints New Chief Marketing and Innovation Officer

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Magle Chemoswed Holding AB Announces the Resignation of Julia Kamber Rouhi from the Board of Directors of Magle Chemoswed Holding

Magle Group Announces First Patients Enrolled in a Post-Market Study of Medical Device SmartPAN®

Magle Chemoswed Holding AB (publ) Announces Post Market Clinical Study for SmartPAN®

Magle Chemoswed Holding AB (publ) to Report Q4, 2022 Results on Feb 16, 2023

Investor sentiment deteriorated over the past week

No independent directors

Full year 2021 earnings released: EPS: kr0.39 (vs kr0.24 in FY 2020)

Magle Chemoswed Holding AB (publ), Annual General Meeting, May 17, 2022

Investor sentiment improved over the past week

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Magle Chemoswed Holding AB (publ) to Report Fiscal Year 2021 Results on Feb 25, 2022

Full year 2020 earnings released: EPS kr0.24

Should You Be Impressed By Magle Chemoswed Holding AB (publ)'s (STO:MAGLE) ROE?

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

New 90-day high: kr44.60

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Magle Chemoswed Holding AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 20 million.

New 90-day high: kr35.00

New 90-day high: kr34.60

Magle Chemoswed Holding AB (publ) to Report Fiscal Year 2020 Results on Apr 14, 2021

New 90-day high: kr33.50

New 90-day high: kr30.90

Magle Chemoswed Holding AB (Publ) Announces the Appointment of Joel Eklund as New Member of the Board

Magle Chemoswed Holding AB (publ) has completed an IPO in the amount of SEK 50 million.

CEO

테뉴어

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령